Prudential Financial’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,399
Closed -$334K 2421
2025
Q2
$334K Buy
3,399
+601
+21% +$56.9K ﹤0.01% 2067
2025
Q1
$259K Buy
2,798
+390
+16% +$36K ﹤0.01% 2009
2024
Q4
$219K Sell
2,408
-125
-5% -$11.5K ﹤0.01% 2067
2024
Q3
$244K Hold
2,533
﹤0.01% 2462
2024
Q2
$233K Sell
2,533
-205
-7% -$19K ﹤0.01% 2440
2024
Q1
$252K Sell
2,738
-80
-3% -$7.5K ﹤0.01% 2397
2023
Q4
$268K Buy
2,818
+448
+19% +$41.8K ﹤0.01% 2360
2023
Q3
$221K Sell
2,370
-1,225
-34% -$113K ﹤0.01% 2364
2023
Q2
$329K Sell
3,595
-173
-5% -$14.2K ﹤0.01% 2269
2023
Q1
$418K Buy
3,768
+229
+6% +$19.8K ﹤0.01% 2147
2022
Q4
$296K Sell
3,539
-360
-9% -$32.5K ﹤0.01% 2263
2022
Q3
$392K Buy
3,899
+8
+0.2% +$954 ﹤0.01% 2181
2022
Q2
$428K Buy
3,891
+163
+4% +$20.8K ﹤0.01% 2200
2022
Q1
$643K Buy
3,728
+90
+2% +$13.4K ﹤0.01% 2084
2021
Q4
$634K Sell
3,638
-113
-3% -$18.2K ﹤0.01% 2109
2021
Q3
$642K Sell
3,751
-12,758
-77% -$2.65M ﹤0.01% 2038
2021
Q2
$4.04M Sell
16,509
-7,053
-30% -$1.85M 0.01% 1115
2021
Q1
$6.24M Sell
23,562
-37,016
-61% -$10.4M 0.01% 943
2020
Q4
$17.8M Buy
60,578
+48,363
+396% +$12.4M 0.03% 501
2020
Q3
$2.89M Buy
12,215
+916
+8% +$208K 0.01% 1151
2020
Q2
$2.24M Sell
11,299
-17,151
-60% -$3.2M ﹤0.01% 1285
2020
Q1
$5.22M Buy
28,450
+5,555
+24% +$988K 0.01% 899
2019
Q4
$3.82M Buy
22,895
+1,236
+6% +$184K 0.01% 1254
2019
Q3
$2.84M Buy
21,659
+88
+0.4% +$11.5K ﹤0.01% 1392
2019
Q2
$2.62M Sell
21,571
-9,350
-30% -$1.11M ﹤0.01% 1470
2019
Q1
$3.81M Sell
30,921
-39,533
-56% -$4.96M 0.01% 1260
2018
Q4
$8.25M Buy
70,454
+10,475
+17% +$1.23M 0.01% 880
2018
Q3
$7.5M Buy
59,979
+10,118
+20% +$1.12M 0.01% 1031
2018
Q2
$4.26M Buy
49,861
+30
+0.1% +$2.2K 0.01% 1291
2018
Q1
$3.01M Buy
49,831
+2,500
+5% +$142K ﹤0.01% 1393
2017
Q4
$2.5M Sell
47,331
-2,500
-5% -$132K ﹤0.01% 1493
2017
Q3
$2.79M Buy
49,831
+2,154
+5% +$114K ﹤0.01% 1412
2017
Q2
$3M Sell
47,677
-505
-1% -$29.4K ﹤0.01% 1362
2017
Q1
$2.46M Sell
48,182
-1,437
-3% -$68.5K ﹤0.01% 1472
2016
Q4
$2.12M Sell
49,619
-1,690
-3% -$71.9K ﹤0.01% 1520
2016
Q3
$2.43M Sell
51,309
-21,970
-30% -$1.1M ﹤0.01% 1414
2016
Q2
$3.7M Sell
73,279
-2,680
-4% -$135K 0.01% 1263
2016
Q1
$3.67M Buy
75,959
+2,100
+3% +$81K 0.01% 1261
2015
Q4
$2.9M Buy
73,859
+3,750
+5% +$150K 0.01% 1329
2015
Q3
$2.66M Sell
70,109
-5,700
-8% -$240K 0.01% 1327
2015
Q2
$3.01M Buy
75,809
+1,450
+2% +$45.2K 0.01% 1362
2015
Q1
$1.99M Buy
74,359
+1,700
+2% +$48K ﹤0.01% 1593
2014
Q4
$2.13M Buy
72,659
+1,500
+2% +$37K ﹤0.01% 1440
2014
Q3
$1.44M Sell
71,159
-2,142
-3% -$41.3K ﹤0.01% 1583
2014
Q2
$1.23M Buy
73,301
+1,342
+2% +$19K ﹤0.01% 1745
2014
Q1
$1.07M Buy
71,959
+700
+1% +$10.8K ﹤0.01% 1725
2013
Q4
$1.04M Sell
71,259
-34,900
-33% -$562K ﹤0.01% 1740
2013
Q3
$1.83M Sell
106,159
-21,416
-17% -$318K ﹤0.01% 1468
2013
Q2
$1.48M Buy
+127,575
New +$1.46M ﹤0.01% 1531

Other funds holding AMED

Prudential Financial's AMED Position: Q3 2025 in Review

Prudential Financial sold out of Amedisys (AMED) in Q3 2025, closing a stake of 3,399 shares — an estimated $334K sold.

Prudential Financial first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $17.8M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Prudential Financial reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Prudential Financial sold 3,399 Amedisys shares in Q3 2025, an estimated $334K.
  • Prudential Financial first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Prudential Financial's Amedisys position peaked at $17.8M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Prudential Financial's 13F filing for Q3 2025, filed 13 Nov 2025.